STXS 주가 차트
STXS 수입
Stereotaxis Inc
$1.94
1.3%
$0.02
오늘 기준:Apr 22, 15:14:48 GMT-4
뒤로
Stereotaxis Inc (STXS) 수입
최신 수익 결과: Q4 '25
보고됨: 2026-03-09
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
STXS의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Stereotaxis Inc STXS의 지난 분기 매출 실적은 어땠나요?
Stereotaxis Inc의 매출 추정치는 얼마인가요?
Stereotaxis Inc의 수익 품질 점수는 얼마인가요?
Stereotaxis Inc는 언제 수익을 보고하나요?
Stereotaxis Inc의 예상 수익은 얼마인가요?
Stereotaxis Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1.92
시가
$1.94
일일 범위
$1.91 - $1.97
52주 범위
$1.74 - $3.59
거래량
223.0K
평균 거래량
493.1K
배당수익률
--
EPS(TTM)
-0.24
시가총액
$189.5M
STXS란 무엇인가요?
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 131 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.